Pinnacle Wealth Planning Services »

BioCryst Pharmaceuticals shares owned by Pinnacle Wealth Planning Services

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Pinnacle Wealth Planning Services from 13F filings

Historical chart of Pinnacle Wealth Planning Services investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Pinnacle Wealth Planning Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Pinnacle Wealth Planning Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $123k 21k 5.99
2020-12-31 $999 143 6.99

More positions owned by Pinnacle Wealth Planning Services

Vaneck Ig Floating Rate Etf Etf (FLTR)
Energy Transfer Equity L P Com Unit Ltd Partnership Stock (ET)
Spdr Portfolio S&p 600 Small Cap Etf Etf (SPSM)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Apple Stock (AAPL)
Microsoft Stock (MSFT)
Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Amazon.com Stock (AMZN)
Fs Kkr Cap Corp Cef (FSK)
Nvidia Corp Stock (NVDA)
Spdr Doubleline Emerging Markets Fixed Income Etf Etf (EMTL)
Ishares Msci Eafe Value Index Etf Etf (EFV)
Ishares Aggregate Bond Etf Etf (AGG)

View all positions for Pinnacle Wealth Planning Services

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Braidwell
Kynam Capital Management
Deerfield Management Company
Fisher Investments
Two Sigma Investments
Jennifer Ranahan
Two Sigma Advisers
Millennium Management
Norges Bank Investment Management
Rice Hall James & Associates
Balyasny Asset Management
Stifel Financial

View all funds holding BioCryst Pharmaceuticals